Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines

Melanoma is an aggressive cancer type with a high mortality rate and an elevated resistance to conventional treatment. Recently, promising new tools for anti-melanoma targeted therapy have emerged including inhibitors directed against frequently overexpressed receptors of growth factors implicated i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dratkiewicz, Ewelina, Pietraszek-Gremplewicz, Katarzyna, Simiczyjew, Aleksandra, Mazur, Antonina Joanna, Nowak, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915070/
https://www.ncbi.nlm.nih.gov/pubmed/29719603
http://dx.doi.org/10.18632/oncotarget.24810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915070/
https://www.ncbi.nlm.nih.gov/pubmed/29719603
http://dx.doi.org/10.18632/oncotarget.24810

Ejemplares similares